Invitation to Participate in a European, Prospective Multicenter Study

ESNM recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID‐19 pandemic
During the peak of the corona virus disease 2019 (COVID‐19) pandemic, care for patients with gastrointestinal motility and functional disorders was largely suspended. In the recovery phases of the pandemic, non‐urgent medical care is resumed, but there is a lack of guidance for restarting and safely conducting motility and function testing. ESNM provides recommendations based on the best current evidence and a pragmatic approach to ensure the safe conduct of motility and function testing for both healthcare professionals and patients.

Gut microbiota and the gut-lung axis in COVID-19
Accumulating data confirm the digestive system involvement in coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2):
•    the presence of SARS-CoV-2 RNA in feces of COVID-19 patients
•    various gastrointestinal symptoms including diarrhea, abdominal pain, nausea and vomiting in many infected patients
•    the expression of angiotensin-converting enzyme 2 (ACE2) receptors – SARS-CoV-2 entry receptors – not only in the lungs but also in the gastrointestinal tract and the liver

ESGE Guidelines on Endoscopic Management of Gastrointestinal Motility Disorders
Therapeutic gastrointestinal endoscopy is rapidly taking a major role in the management of motility disorders of the digestive tract. Indeed, several disorders like achalasia, GERD, gastroparesis, intractable constipation, can be potentially currently managed by interventional endoscopy. Because of that, recently, the ESGE and ESNM put some efforts in order to provide guidance on various aspects of the endoscopic management of GI motility disorders with two guidelines papers published in Endoscopy and freely available from every physician who wants to improve his knowledge on the topic. Part 1 DOI: 10.1055/a-1160-5549 Part 2 DOI: 10.1055/a-1171-3174

ESNM Teaching Video: Emerging Therapies for Eosinophilic Esophagitis

Graphical Abstract: Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial

In a recent study published in United European Gastroenterology Journal, researchers from Aalborg University Hospital found that Liraglutide accelerated transit time and motility index in the large bowel of adults with type 1 diabetes and concomitant polyneuropathy, while expected prolonged gastric emptying and nausea subsided. Click on the link to read full article

DOI: 10.1177/2050640620925968

Graphical Abstract: Pyloric Distensibility Measurement after Gastric Surgery: which Surgeries are Associated with Pylorospasm?

History of gastric surgery is found in 10% of patients with gastroparesis, and vagal lesion is often suspected to be the cause of pylorospasm. Recently, pyloric distensibility measurement using the EndoFLIP® system showed that pylorospasm was present in 30%‐50% of gastroparetic patients. Our objective was to assess whether pylorospasm, diagnosed using EndoFLIP® system was observed in three different types of gastric surgeries: antireflux surgery, sleeve gastrectomy, and esophagectomy. Click on the link to read full article

DOI: 10.1111/nmo.13790

GENIEUR Lobbying - next EU Research Framework Programme 2021-2027

The funding of research is a basic prerequisite for our work and we are therefore closely following the current negotiations on the funding of the next EU Research Framework Programme 2021 to 2027, which is important for all of us. The proposed 120 billion budget by the Parliament, was cut to 94.1 by the European Commission, for the entire EU over the six years period.

Rome Foundation Key Data on Prevalence & Burden of Functional GI Disorders from Global Epidemiology Study

In a population survey of over 73,000 participants in 33 countries, close to 40% of the entire study population met diagnostic criteria for at least one functional gastrointestinal disorder. The study reflects Rome Foundation’s continued commitment to advancing the science and moving us forward in understanding Disorders of Gut-Brain Interaction. It also confirms the Rome Foundation as an organization with a truly global reach. The epidemiological basis and additional data analyses that stem from this important study will impact the field for years to come.

DOI: 10.1053/j.gastro.2020.04.014

ESNM Encourages Exchange in Europe

Report of Anja Radovan, a second-year gastroenterology resident in UHC Rijeka, Croatia. She took the opportunity to learn about oesophageal and anorectal manometry from Ass. Prof. Edoardo Savarino, at the University hospital of Padova, Department of Surgery, Oncology and Gastroenterology.